RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
NCT02864628
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Protocol was withdrawn from IND
Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL:
MVA-BN-RSV
OTHER:
Placebo
Sponsor
Bavarian Nordic